Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Arthritis Rheumatol. 2021 Sep 26;73(11):2096–2104. doi: 10.1002/art.41779

Figure 2. Causal effect estimates for genetically determined concentration of fasting insulin (per log pmol/L) on concentrations of serum urate (mg/dL) (A) and odds of gout (B), ascertained in individuals without diabetes, two-sample analysis.

Figure 2

SNP=single nucleotide polymorphism. One of the candidate risk SNPs for fasting insulin was removed during harmonisation due to ambiguity in the strand direction, leaving 80 in the final analysis.